![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessProceedings of the 23rd Paediatric Rheumatology European Society Congress: part one
-
Article
Open AccessA child with resistant Kawasaki disease successfully treated with anakinra: a case report
Kawasaki disease (KD) is an acute self-limited systemic vasculitis of unknown etiology. Intravenous immunoglobulin (IVIG) is an effective treatment and decreases the risk of cardiac complications to less than ...
-
Article
Open AccessEvidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis
Macrophage activation syndrome (MAS) is a severe and potentially lethal complication of several inflammatory diseases but seems particularly linked to systemic juvenile idiopathic arthritis (sJIA). Standardize...
-
Article
Open AccessGenetic and phenotypic characteristics of 114 patients with mevalonate kinase deficiency
-
Article
Open AccessLong-term efficacy and safety of Canakinumab in active Hyper-IgD syndrome (HIDS): results from an open-label study
-
Article
Open AccessRecommendations for the management of autoinflammatory diseases
-
Article
Open AccessClinical and genetic features of Spanish patients with Mevalonate kinase deficiency
-
Article
Open AccessPerspective validation of the eurofever classification criteria for monogenic periodic fevers
-
Article
Open AccessPredictors of response in patients with active systemic JIA (SJIA) receiving canakinumab: an exploratory analysis of pooled 12-week data
-
Article
Open AccessPReS-FINAL-1005: Hypertransaminasemia in systemic juvenile idiopathic arthritis during anti-interleukin 1 treatment
-
Article
Open AccessPReS-FINAL-2063: Proposed criteria for activity, damage and impact of juvenile idiopathic arthritis associated uveitis: consensus effort from the multinational interdisciplinary working group for uveitis in childhood (MIWGUC)
-
Article
Open AccessPReS-FINAL-1014: Role of MHC class I overexpression on muscle biopsy of patients with juvenile dermatomyositis
-
Article
Open AccessPReS-FINAL-2337: The eurofever registry: 3 years of enrollment
-
Article
Open AccessPReS-FINAL-1013: Magnetic resonance imaging as a non-invasive tool to assess muscle edema in juvenile dermatomyositis. Return to normal after treatment
-
Article
Open AccessPReS-FINAL-2330: Canakinumab treatment in patients with HIDS
-
Article
Open AccessPReS-FINAL-2319: PED-BD cohort 2013: expert consensus classification gives higher sensitivity than the international study group criteria to define Behcet's disease in children
-
Article
Open AccessPW02-008 - TRAPS in the real world: an international registry
-
Article
Open AccessPW03-016 – Blau prospective cohort study: articular outcomes
-
Article
Open AccessDisease activity in paediatric vasculitis: development of a generic assessment tool - PVAS
-
Article
Open AccessJuvenile localized scleroderma: review of 44 patients